Carisbamate add-on therapy for drug-resistant focal epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

twitter: 7 tweeters
facebook: 1 Facebook page

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 42 Mendeley

Summary Twitter Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 7 tweets from 7 users, with an upper bound of 291,746 followers.

Carisbamate add-on therapy for drug-resistant focal epilepsy https://t.co/4d4aYl8BRw

Reply Retweet Favourite

RT @CochraneLibrary: #Carisbamate add‐on therapy for drug‐resistant focal #epilepsy ➡️ https://t.co/ubSHc9dAeN - New @CochraneEpileps syst…

Reply Retweet Favourite

RT @CochraneLibrary: #Carisbamate add‐on therapy for drug‐resistant focal #epilepsy ➡️ https://t.co/ubSHc9dAeN - New @CochraneEpileps syst…

Reply Retweet Favourite

#Carisbamate add‐on therapy for drug‐resistant focal #epilepsy https://t.co/kBSsdYAOWR - New @CochraneEpileps systematic review looks at the evidence from 4 studies including 2211 participants. https://t.co/o2j1elCXtr

Reply Retweet Favourite

RT @CochraneLibrary: #Carisbamate add‐on therapy for drug‐resistant focal #epilepsy ➡️ https://t.co/ubSHc9dAeN - New @CochraneEpileps syst…

Reply Retweet Favourite

#Carisbamate add‐on therapy for drug‐resistant focal #epilepsy ➡️ https://t.co/ubSHc9dAeN - New @CochraneEpileps systematic review looks at the evidence from 4 studies including 2211 participants. https://t.co/C9XUF4M3RW

Reply Retweet Favourite

Carisbamate add-on therapy for drug-resistant focal epilepsy https://t.co/P1dhxMbVYD

Reply Retweet Favourite